# Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

> **NCT00002534** · PHASE3 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** cyclophosphamide
- **DRUG:** cytarabine
- **DRUG:** methylprednisolone
- **DRUG:** thiotepa
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** in vitro-treated bone marrow transplantation
- **RADIATION:** low-LET electron therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002534
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-05
- **Primary completion:** 2003-04
- **Final completion:** 2003-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002534, "Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00002534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*